Septic Pseudarthrosis Of Long Bone : Experience In A Regional Reference Center

Pseudoarthrosis of Bone Clinical Trial

Official title:

Septic Pseudarthrosis Of Long Bone : Experience In A Regional Reference Center

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03620305
• Other study ID #: 18-078
• Status: Completed
• Start date: April 1, 2018
• Est. completion date: December 30, 2018

Study information

• Verified date: February 2019
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Description of septic pseudarthrosis with chirurgical treatment in two steps (first step : Implementation of cement, second step : bone reconstruction, with or without device)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: December 30, 2018
• Est. primary completion date: December 30, 2018
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• patients having septic pseudarthrosis of long bone treated at the CRIOAc LYON

Exclusion Criteria:

Related Conditions & MeSH terms

• Pseudarthrosis
• Pseudoarthrosis of Bone

Intervention

Other:
• Description of treatment of septic pseudarthrosis
description of chirurgical 2 steps management of septic pseudarthrosis

Locations

Country	Name	City	State
France	Hospices Civils de Lyon	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Description of treatment of septic pseudarthrosis : chirurgical treatment - rate of use of this type of chirurgical treatment among patients with septic pseudarthrosis	Description of treatment of septic pseudarthrosis : chirurgical treatment	Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)
Secondary	Description of treatment of septic pseudarthrosis : medical treatment - duration of treatment in patients having sepstic pseudarthrosis	Description of treatment of septic pseudarthrosis : medical treatment	Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)
Secondary	Treatment failure : rate of failure with this 2 times chirurgical treatment	Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin	Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)